Tirzepatide

Name: Tirzepatide
Brand: Peak Research Peptides
SKU: PRP-TIRZEPATID
Price: 75.00 USD
Availability: InStock

Dual GIP/GLP-1 receptor research peptide supplied for in-vitro receptor-binding research.

Receptors & targets

GIP-RGLP-1R

Sequence / structure

39-amino-acid dual GIP/GLP-1 receptor peptide with C20 fatty-diacid moiety.

Handling

Storage: Store lyophilized at −20 °C. Protect from light.

Verified before release

Every lot of Tirzepatide is analysed against the specification below before any vial is released.

≥0.00%purity by HPLC · specification ≥ 95%

Parameter	Result	Method	Specification
Appearance	White lyophilised powder	Visual	White lyophilised powder
Purity	≥ 99.00%	HPLC	≥ 95%
Identity	Confirmed	HPLC / MS	Meets specification
Heavy metals	Not detected	ICP-MS	Pass
Sterility	No growth	PCR	Pass
Endotoxin	Within limit	USP <85>	Report

Analysis is carried out on every lot before release. If you are supplying material onward, run your own confirmatory testing on arrival — our work supports yours, it does not replace it.

Specification

Presentation: 10 mg / vial
Molecular formula: C225H348N48O68
Molecular weight: 4813.5 g/mol
CAS: 2023788-19-2
Grade: Research use only (RUO)

$75.00

Dosage

10 mg / vial — sold out

For laboratory and research purposes only. Not for human or animal consumption.

Published literature

Peer-reviewed research on Tirzepatide, indexed in PubMed. Listed so you can read the primary sources directly.

N Engl J Med
Tirzepatide for Obesity Treatment and Diabetes Prevention
Jastreboff AM, le Roux CW, Stefanski A et al.
2025PMID 39536238DOI
Diabetes Obes Metab
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight
Look M, Dunn JP, Kushner RF et al.
2025PMID 39996356DOI
N Engl J Med
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Aronne LJ, Horn DB, le Roux CW et al.
2025PMID 40353578DOI
Drugs
Tirzepatide: A Review in Type 2 Diabetes
France NL, Syed YY
2024PMID 38388874DOI
JAMA
Tirzepatide for Weight Reduction in Chinese Adults With Obesity: The SURMOUNT-CN Randomized Clinical Trial
Zhao L, Cheng Z, Lu Y et al.
2024PMID 38819983DOI
N Engl J Med
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
Loomba R, Hartman ML, Lawitz EJ et al.
2024PMID 38856224DOI

These papers are the published research on this molecule. They are not a claim about this product, and nothing here describes an intended use. All material is supplied for laboratory research only.